Volume | 36,833 |
|
|||||
News | - | ||||||
Day High | 16.87 | Low High |
|||||
Day Low | 16.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
16.35 | 16.35 | 16.87 | 16.34 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
941 | 36,833 | $ 16.68 | $ 614,210 | - | 11.33 - 25.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:29:05 | 14 | $ 16.59 | USD |
Tarsus Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
539.8M | 32.62M | - | 25.82M | -62.09M | -1.90 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 16.61 | 17.72 | 15.89 | 16.83 | 348,701 | -0.06 | -0.36% |
1 Month | 17.31 | 17.77 | 14.61 | 16.34 | 399,440 | -0.76 | -4.39% |
3 Months | 17.30 | 25.25 | 14.61 | 18.14 | 470,105 | -0.75 | -4.34% |
6 Months | 12.05 | 25.25 | 11.33 | 17.47 | 324,595 | 4.50 | 37.34% |
1 Year | 15.97 | 25.25 | 11.33 | 17.12 | 203,902 | 0.58 | 3.63% |
3 Years | 18.30 | 63.69 | 10.8001 | 19.37 | 122,526 | -1.75 | -9.56% |
5 Years | 18.30 | 63.69 | 10.8001 | 19.37 | 122,526 | -1.75 | -9.56% |
Tarsus Pharmaceuticals Description
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |